RT Journal Article
SR Electronic
A1 Vinall, Maria
T1 MODERATO Study to Assess the Effect of Rasagiline on Patients With Parkinson Disease and Mild Cognitive Impairment
JF MD Conference Express
YR 2015
FD SAGE Publications
VO 15
IS 9
SP 9
OP 9
DO 10.1177/1559897715588474
UL http://mdc.sagepub.com/content/15/9/9.abstract
AB Parkinson disease (PD) with mild cognitive impairment (PD-MCI) is relatively common in nondemented PD patients, but currently there is no approved treatment. The phase 4 MODERATO is evaluating the effect of 24 weeks of treatment with rasagiline 1 mg/d as add-on therapy in adults with PD-MCI. The trial, which has enrolled 170 patients, is the largest to date to evaluate a treatment for PC-MCI.